A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gefitinib Impurity 33 | CAS 26791-93-5 - Request Quote

Picture of Gefitinib Impurity 33

Gefitinib Impurity 33

SZ CAT No:SZ-G018052
CAS No
26791-93-5
Mol.F.
C10H11NO6
Mol.Wt.
241.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gefitinib Impurity 33 is chemically Methyl 4,5-dimethoxy-2-nitrobenzoate. Gefitinib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 26791-93-5

Purchase 26791-93-5

Order 26791-93-5

Enquire 26791-93-5

price of 26791-93-5

26791-93-5 Supplier

26791-93-5 Manufacturer

26791-93-5 Exporter

buy high quality Gefitinib Impurity 33

Purchase Gefitinib Impurity 33

Gefitinib Impurity 33 suppliers

Gefitinib Impurity 33 manufacturers

Gefitinib Impurity 33 price

Order Gefitinib Impurity 33

Enquire Gefitinib Impurity 33

Gefitinib Impurity 33 cost

Gefitinib Impurity 33 Supplier

Gefitinib Impurity 33 Distributor

Gefitinib Impurity 33 for Method Validation

Gefitinib Reference Standard

Gefitinib Impurity 33 for ANDA Filing

Gefitinib Impurity 33 for Forced Degradation Studies

Gefitinib Impurity 33 Identification Standards

Gefitinib Impurity 33 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,